Professional Documents
Culture Documents
Ksmu Department of Clinical Pharmacology
Ksmu Department of Clinical Pharmacology
• The optimal dose of a drug used during pregnancy should maximize therapeutic
benefit while minimizing the risk of damage or toxicity to the mother, fetus, and
placenta. Obviously, too high a dose could cause toxic effects, out of proportion to
therapeutic benefits. Less obviously, too low a dose may deny women any benefits of
treatment, while still exposing them to some risk.
• Determining the best dose is difficult because a woman’s ability to metabolize and
excrete drugs, as well as her body’s response to drugs, changes dramatically over the
course of her pregnancy. A case in point is that most drugs are eliminated from the
body either by enzymes in the liver or by excretion into the urine, and the activity of
both of these processes can be increased by up to 50% in most pregnant women. This
fact is rarely taken into account.
• It is a basic principle of pharmacology that, when we weigh potential harms of a drug
treatment, we should do so at a dose and dosing interval that maximizes potential
benefit. Unfortunately, we lack this sort of dosing information for almost all drugs
prescribed to pregnant women.
• Most women will require one or more prescription drugs during pregnancy despite
the fact that almost no commonly used drugs have been tested specifically for their
use in pregnancy. Consequently, while we always have some information about fetal
safety (more often in animals than in humans), we know almost nothing about
maternal safety, about choosing the right dose for a pregnant woman, or about how
effective the drug will be during pregnancy.
RISK CATEGORIES FOR USING DRUGS DURING PREGNANCY
DEVELOPED BY THE AMERICAN FOOD AND DRUG
ADMINISTRATION — FOOD AND DRUG ADMINISTRATION):
RISK CATEGORIES FOR USING DRUGS DURING
PREGNANCY